您现在所在的位置:首页 > 疾病百科 > 外科 > 肛肠外科 > 大肠癌 > 文献资料 >  正文
专题推荐
栏目热图

bcl-2,c-myc和p53在大肠腺瘤和大肠癌中的表达

正文字体:  
日期:2006-11-22 来源:景天阁健康资讯
内容提示:探讨癌基因bcl-2,c-myc和p53在大肠腺瘤与大 肠癌中的表达情况及与临床病理特征的关系。方法采用免疫组化ABC法, 检测63例大肠癌和40例大肠腺瘤的bcl-2,c-myc和p53表达。结果bcl -2,c-myc和p53在大肠腺瘤中的表达分别为72。0%(18/40) ,而在大肠癌中的表达则依次为34。

  探讨癌基因bcl-2,c-myc和p53在大肠腺瘤与大 肠癌中的表达情况及与临床病理特征的关系。方法 采用免疫组化ABC法, 检测63例大肠癌和40例大肠腺瘤的bcl-2,c-myc和p53表达。结果 bcl -2,c-myc和p53在大肠腺瘤中的表达分别为72.7%(24/33)、62.2%(23/37)和45.0%(18/40) ,而在大肠癌中的表达则依次为34.0%(16/47)、82.1%(32/39)和84.1%(53/63)。三个癌基因 在大肠腺瘤和大肠癌中的表达均有显著的统计学意义(P<0.01),但三个癌基因的表达与 临床病理特征无显著的相关性。结论 bcl-2基因的异常激活在肿瘤的发 展和演变出现较早,而c-myc和p53的表达则较迟,且两者起协同作用。

  分类号:R735.3+4  文献标识码:A

  文章编号:1001-8174(2000)02-0081-02

Expression of bcl-2,c-myc and p53 in Colorectal Adenoma and Carcinoma

SUN Yan-xiang ZHOU Han-gao CHEN Chong-jia FENG Wei-ying

  (Shibei Hospi tal of Shanghai,Shanghai 200435,China)

  SHI Ying-qiang ZHENG Song-guo LUO Jian-min

  (Cancer Hospital,Shanghai Medical Univers ity,Shanghai 200032,China)

  Abstract:Objective To investigate the expressions of on cogenes bcl-2,c-myc and p53 in colorectal adenoma and adenocarcinoma,and the relationship between the expression of oncogene and clinical pathological features.Method Expression of oncogene bcl-2 were determinated in 33 cases of colorectal adenomas and 47 cases of colorectal carcinomas by the immunohistochemical method(ABC method).Expression of p53 in 40 cases of colotectal a denomas and 63 cases of colorectal carcinomas,in addition to c-myc protein in 3 7 cases of adenoma and 39 cases of colorectal adenocarcinomas were also determinated.Results The positive expression rates of bcl-2 in colorec tal adenoma and adenocarcinoma were 72.2%(24/33) and 24.2%(16/47) respectively,and those of p53 were 45.0%(18/40) and 84.1%(53/63) respectively.The Positive sta ining rates of c-myc in colorectal adenoma and adenocarcinoma were 62.7%(23/37) and 82.1%(30/39) respectively.There were significant differences between the expressions of these three oncogenes in colorectal adenoma and in adenocarcinoma( P<0.01).However,the expression of these three oncogenes were not correlated with clinical pathological features.Conclusions The abnormal activation in bcl-2 takes place earlier during the development and progression of colorectal adenocarcinoma.But c-myc and p53 express later and cooperate with each other in progression of colorectal adenocarcinoma.

  Key words:bcl-2;p53;c-myc;Cellar apoptosis;Colorectal carcino mas

  业已证明,bcl-2抑制由野生型p53激发的细胞凋亡,且突变的p53也显示抑制细胞凋亡 。而c-myc与p53的共同表达在肿瘤的发展过程中可能起协同作用。大肠肿瘤提供了研究肿瘤的理想模式,即大多数癌似乎来源于腺瘤。并可分析各期肿瘤的发展情况。作者分析了bcl-2和c-myc在正常粘膜、腺瘤和癌肿时的表达情况。

返回顶部 | 关闭窗口 | 打印页面 | 发表评论(共有 条)】
相关文章
延伸阅读
发表评论
网站图文更新
最新新闻
热门疾病
疾病图文
网站推荐
互动论坛
关于我们|联系我们|广告投放|商务合作|友情链接相关法律|网站地图|RSS|XML|MAP
Copyright © 2004-2008 Jttop.com Inc. All rights reserved. 景天阁 健康资讯[景天阁两性天地] 版权所有
合作联系QQ:550036 Email:jttop@163.com 中国电信提供网络带宽 粤ICP备05004651号
本站所供内容仅供参考,不可替代医生意见,请谨慎使用部分部分内容来自网络,本站转载仅为传播信息,如有转载或引用文章涉及版权问题,或侵犯了您的权益,请及时与我们联系,我们将在收到通知后撤销该部分内容。